`Q5100` Inj ustekinumab-kfce, 1 mg

Injection, ustekinumab-kfce (yesintek), biosimilar, 1 mg

Medicare coverage: Carrier judgment
Status: active (July 2026 file)
MUE: max 520 units per day (practitioner), rationale: Prescribing Information